Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2000

View Archived Issues

FDA clears new dose of Concerta for ADHD

Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery

EntreMed commences phase I trial of Angiostatin by s.c. injection

Forest reports successful completion of phase III escitalopram clinical trial

Guilford seeks E.U. approval to begin trials of novel anesthetic and analgesic agents

British Biotech updates product development programs

First-in-class antithrombotic demonstrates benefits over comparators in preventing DVT

Amgen finalizes Kinetix acquisition

FDA approves pediatric indication for Tamiflu

Schering-Plough seeks additional FDA approval for Rebetol capsules

Another major merger announced

AeroGen begins phase II clinical trials with AeroDose insulin inhaler

Pharmacia returns rights to glaucoma diagnostic to InSite Vision

Anti-TNF-alpha MAb effective against spondyloarthropathy associated with Crohn's disease

Novel Yamanouchi compound activates gene expression, translocation of Glut4

Orally active HNE inhibitor in clinical trials at Ono

New antiretroviral Kaletra granted positive opinion in E.U.

Arzoxifene has identical effects to tamoxifen in endometrial cancer models

S-1 appears to safely improve survival in metastatic breast cancer patients

Nortran's phase II clinical trial of CP1 fails to meet primary endpoint

Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis

Large group of MEK-inhibitory quinolines discovered at AstraZeneca

Inhibitors of Lp-PLA2 and their use in atherosclerosis described by SB in recent patent

Merck Frosst synthesizes potent, selective and orally active PDE4 inhibitors

Two series of inhibitors of alpha4beta1-mediated cell adhesion claimed by Aventis

Vitamin D-like effects discovered in novel Roche compounds

Dipeptide caspase, apoptosis inhibitors designed by Cytovia research team

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.